Any process that modulates the frequency, rate or extent of double-strand break repair via nonhomologous end joining.

Any process that stops, prevents or reduces the frequency, rate or extent of double-strand break repair via nonhomologous end joining.

Any process that activates or increases the frequency, rate or extent of cellular glucuronidation.

Any process that modulates the frequency, rate or extent of cellular glucuronidation.

The process in which cellular structures, including whole cells or cell parts, are generated and organized.

Any process that modulates the frequency, rate or extent of cellular response to drug.

Any process that activates or increases the frequency, rate or extent of tongue muscle cell differentiation.

Any process that modulates the frequency, rate or extent of tongue muscle cell differentiation.

OBSOLETE. Catalysis of the hydrolysis of dipeptides, preferentially hydrophobic dipeptides including prolyl amino acids.

Any process that stops, prevents or reduces the frequency, rate or extent of tongue muscle cell differentiation.

Any process resulting in the inhibition or termination of the activity of protein kinase C.

Any process that stops, prevents or reduces the frequency, rate or extent of cellular glucuronidation.

A protein complex containing Bcl3 and Bcl10, which forms when Akt1 is activated by TNF-alpha to phosphorylate Bcl10; the Bcl3-Bcl10 complex is translocated to the nucleus.

A protein complex composed of an Fc-alpha R alpha chain and an Fc-epsilon RI gamma chain dimer with or without additional signaling components. The complex functions primarily as an activating receptor for IgA.

Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to drug.

A protein complex composed of an Fc-epsilon RI alpha chain and an Fc-epsilon RI gamma chain dimer with or without an Fc-episilon RI beta chain and additional signaling components. The complex functions primarily as an activating receptor for IgE.

Any process that stops, prevents or reduces the frequency, rate or extent of integrin-mediated signaling pathway.

Any process that modulates the frequency, rate or extent of integrin-mediated signaling pathway.